Intratumor heterogeneity (ITH) of bladder cancer (BLCA) contributes to therapy resistance and immune evasion affecting clinical prognosis. The molecular and cellular mechanisms contributing to BLCA ITH generation remain elusive. It is found that a TM4SF1‐
Yongwen Luo +26 more
core +1 more source
Development and validation of a ferroptosis and metabolic reprogramming gene signature for risk stratification in bladder urothelial carcinoma: A retrospective multicohort study. [PDF]
Ma Y, Zhang Z, Tang L, Li Q, Zhao Y.
europepmc +1 more source
A candidate PPARγ to GPX4 axis in ferroptosis suppression and platinum resistance in bladder cancer: evidence appraisal and a testable research agenda. [PDF]
Li S +11 more
europepmc +1 more source
Yancheng Di, Lingling Zhang, Linlin Zhao, Lei Yin Department of Urology, Hongqi Hospital Affiliated to Mudanjiang Medical University, Mudanjiang, 157000, People’s Republic of ChinaCorrespondence: Lei Yin, Department of Urology, Hongqi Hospital Affiliated
Di Y, Zhang L, Zhao L, Yin L
doaj
Identification and experimental validation of prognostic genes associated with dietary restriction-related signatures in bladder cancer. [PDF]
Wu X, Sun T, Liu Z.
europepmc +1 more source
PAK4-targeting PROTAC inhibits bladder cancer cell proliferation. [PDF]
Xu S +7 more
europepmc +1 more source
Pan-cancer screening and integrative multi-omics and deep learning reveal the prognostic significance of an IBD-CRC shared host-microbe signature in bladder urothelial carcinoma. [PDF]
Zhan C +9 more
europepmc +1 more source
Pentachlorophenol enhances bladder cancer cell invasion through altered protein stability. [PDF]
Zhou R +7 more
europepmc +1 more source
Retraction: Mechanistic Analysis of the Role of BLCA-4 in Bladder Cancer Pathobiology [PDF]
openaire +1 more source
Urine-derived induced pluripotent stem cells for non-invasive diagnosis of bladder cancer. [PDF]
Zhu Y +14 more
europepmc +1 more source

